Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers
Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers
Cibus' Rice Herbicide Tolerance (HT-3) Commercialization Efforts Continue Promising Progress to deliver a new Weed Management Solution for Farmers in the U.S.
Cibus的水稻除草劑耐受性(Ht-3)商業化努力持續取得積極進展,爲美國農民提供新的雜草管理解決方案。
Cibus and its partners Albaugh and RTDC Continue Their Research and Development Collaboration to Enable Commercialization of Cibus' Clethodim-Tolerant HT-3 Rice Trait
Cibus與其合作伙伴Albaugh和RTDC繼續進行研發合作,以推動Cibus的Clethodim耐受性Ht-3水稻性狀的商業化。
SAN DIEGO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties announced an agreement affirming its collaboration with RTDC Corporation Limited and Albaugh LLC to provide Clethodim as part of Cibus' weed management solution for U.S. rice farmers using Cibus' HT-3 trait. This continued collaboration with Albaugh, a global leader in crop protection, lends complementary market development and herbicide registration expertise and experience to Cibus' gene editing trait expertise. The collaboration is instrumental to Cibus' herbicide resistant rice trait commercialization efforts as Cibus also continues its work with its U.S. rice seed customers to bring its Clethodim-tolerant trait to market. These seed and crop protection collaborations are expected to bring together the rice production knowledge and expertise needed to successfully deliver improved rice weed management solutions for U.S. rice growers.
聖地亞哥,2024年12月16日(環球新聞通訊社) - Cibus公司(納斯達克:CBUS)是一家領先的農業科技公司,開發並許可植物性狀給種子公司以獲取特許權使用費,宣佈與RTDC有限公司和Albaugh LLC達成協議,確認其合作,爲使用Cibus的Ht-3特性的美國水稻農民提供Clethodim作爲Cibus的雜草管理解決方案。這種與全球作物保護領導者Albaugh的持續合作,爲Cibus在基因編輯特性方面的專長提供了附加的市場開發和除草劑註冊專業知識與經驗。這一合作對Cibus的除草劑抗性水稻性狀商業化努力至關重要,因爲Cibus還繼續與其美國水稻種子客戶合作,將其Clethodim耐受性特性推向市場。這些種子和作物保護的合作預計將匯聚水稻生產的知識和專業技能,以成功提供改進的美國水稻農民雜草管理解決方案。
Weed pressure impacts crop yield and quality. Herbicide tolerance traits are an important tool for growers to manage weeds and are a key product area of the multi-billion-dollar trait industry globally. Cibus' Clethodim tolerant HT-3 trait is an important breakthrough for a novel weed management solution for rice farmers and is one of the two herbicide tolerant traits in rice developed by Cibus that are expected to give rice growers excellent new solutions to manage weeds. It expected to be the first of several stacked weed management traits in rice from Cibus. Cibus currently has four seed partners for this trait: two in the United States and two in South America and is in discussion with other major rice seed companies to advance HT-3 rice in Asia.
雜草壓力影響作物產量和質量。除草劑耐受性狀是種植者管理雜草的重要工具,也是全球數十億美元性狀行業的一個關鍵產品領域。Cibus的Clethodim耐受性Ht-3性狀是水稻農民新型雜草管理解決方案的重要突破,是Cibus開發的兩種除草劑耐受性狀之一,預計將爲水稻種植者提供出色的新解決方案來管理雜草。它預計將是Cibus在水稻領域推出的幾種疊加雜草管理性狀中的第一個。Cibus目前在這一性狀方面有四個種子合作伙伴:兩個在美國,兩個在南美,並正在與其他主要水稻種子公司討論,以推動Ht-3水稻在亞洲的發展。
Chad W. Shelton, Albaugh's Group Director for Herbicide Tolerant Crops, stated, "This strategic collaboration and innovative technology has a strong potential to help rice growers in the U.S. and strategic rice markets around the globe keep pace with the most up-to-date herbicide-tolerant crop technologies for assuring high yields and crop quality. Albaugh is excited to be a part of this strategic partnership to develop for rice growers a cropping system powered by the HT-3 trait to help create and deliver performance value."
Chad W. Shelton,Albaugh的農藥耐受作物集團董事表示:"這項戰略合作和創新技術具有很大的潛力,能夠幫助美國及全球戰略稻米市場的稻農跟上最新的農藥耐受作物技術,以確保高產量和作物質量。Albaugh很高興能參與這項戰略合作伙伴關係,爲稻農開發一種由Ht-3性狀驅動的種植系統,以幫助創造和提供業績價值。"
Calvin Lu, Vice General Manager of RTDC, commented, "This technology combines the best of Gene Editing technologies from Cibus and superior herbicides provided by Albaugh to help rice growers to increase weed management options with better efficacy against difficult weeds. We are proud to be part of this project combining strengths of three companies in terms of technologies and geographies."
RTDC副總經理Calvin Lu評論道:"這項技術結合了Cibus的基因編輯技術和Albaugh提供的優質農藥,幫助稻農增加更有效的雜草管理選項,針對難處理的雜草效果更佳。我們爲能夠參與這個項目而感到自豪,三家公司在技術和地理上的優勢得到了充分結合。"
Norm Sissons, Senior Vice President of Seeds and Traits at Cibus, added, "This partnership with Albaugh completes a critical component of our commercial strategy to bring our Clethodim-tolerant HT-3 trait to market. As we further our collaboration with Albaugh and its professional team of experts with a strong commercial focus enabling getting products to market, we see a promising path to bring Cibus' novel weed management solution to Rice growers."
Cibus的種子和性狀高級副總裁Norm Sissons補充道:"與Albaugh的這一合作完成了我們商業策略中的一個關鍵組成部分,以將我們的Clethodim耐受Ht-3萬億.ait推向市場。隨着我們與Albaugh及其專業專家團隊的進一步合作,其強大的商業焦點使得我們能夠將產品推向市場,我們看到了一條有前景的道路,將Cibus的創新雜草管理解決方案帶給稻農。"
About Cibus
關於Cibus
Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' long-term focus is productivity traits for farmers for the major global row crops with large acreage such as canola, rice, and soybean. Cibus is a technology leader in high-throughput gene editing technology that is expected to enable it to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a current pipeline of five productivity traits including important traits for weed management in Rice, Pod Shatter Reduction, and Sclerotinia (disease) resistance, which are its near-term focus.
Cibus是基因編輯生產率特徵的領導者,旨在解決農民面臨的關鍵生產力和可持續性挑戰,例如疾病和害蟲,據聯合國估計,這每年給全球經濟造成約3000億的損失。Cibus不是一家種子公司,而是一家科技公司,通過基因編輯開發和許可特徵給種子公司,以換取種子銷售的特許權使用費。Cibus的長期重點是主要全球大宗作物(如油菜、稻米和大豆)的生產力特徵,這些作物的種植面積很大。Cibus在高通量基因編輯技術方面是一個科技領導者,預計能夠以常規育種的極小時間和成本開發和商業化植物特徵。Cibus目前已開發出五種生產力特徵,包括針對稻米的雜草管理的重要特徵、莢果破裂減少和白粉病(疾病)抗性,這些都是其近期重點。
Forward-Looking Statements
前瞻性聲明
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as "anticipates," "believes," "continue," "estimates," "expects," "intends," "may," "might," "plans," "predicts," "projects," "should," "targets," "will," or the negative of these terms and other similar terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding the anticipated closing of the offering and the expected use of the proceeds from the offering. Completion of the offering is subject to numerous factors, many of which are beyond Cibus' control, including, without limitation, market conditions, failure to satisfy customary closing conditions and the risk factors and other matters set forth in the prospectus supplement and accompanying prospectus included in the registration statement and the documents incorporated by reference therein. You are cautioned not to place undue reliance on any forward-looking statements made by Cibus' management, which are based only on information currently available to it when, and speak only as of the date, such statement is made. Cibus does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by law.
本新聞稿包含根據1995年美國《私人證券訴訟改革法》安全港條款的定義的「前瞻性陳述」。在某些情況下,您可以通過前瞻性詞彙識別這些陳述,例如:「預期」、「相信」、「繼續」、「估計」、「期待」、「打算」、「可能」、「也許」、「計劃」、「預測」、「項目」、「應該」、「目標」、「將」或這些術語的否定形式及其他類似術語。本新聞稿中的前瞻性陳述包括但不限於關於預期完成發售及預計使用發售收益的說明。完成發售受許多因素的影響,其中許多因素超出了Cibus的控制,包括但不限於市場條件、未能滿足習慣性關閉條件以及在刊登的招股說明書和註冊聲明及其所包含的文件中列出的風險因素和其他事項。您被警告不要對Cibus管理層做出的任何前瞻性陳述過於依賴,這些陳述僅基於在陳述作出時Cibus所能獲得的信息,並只限於該陳述做出之日。Cibus不承擔公開提供對任何前瞻性陳述的修改或更新的義務,無論是由於新信息、未來發展或其他原因,除非法律另有要求。
CIBUS CONTACTS:
CIBUS 聯繫人:
INVESTOR RELATIONS
Karen Troeber
ktroeber@cibus.com
858-450-2636
投資者關係
凱倫·特羅伯
ktroeber@cibus.com
858-450-2636
Jeff Sonnek – ICR
jeff.sonnek@icrinc.com
傑夫·索尼克 – ICR
jeff.sonnek@icrinc.com
MEDIA RELATIONS
Colin Sanford
colin@bioscribe.com
203-918-4347
媒體關係
科林·桑福德
colin@bioscribe.com
203-918-4347
譯文內容由第三人軟體翻譯。